Biosimilar development technology consulting business can cover a wide range of disease fields, covering ophthalmic diseases, respiratory diseases, orthopedic diseases, neurological diseases,
immune system diseases, cardiovascular diseases, cancer, etc.; Molecular entities are diverse, including monoclonal antibodies, bispecific antibodies, recombinant proteins, XDCs, oligonucleotides, etc. The specific business is project initiation consultation, CMC strategy formulation, technical consultation related to stock solution and preparation, registration application, etc. This technical consulting helps companies achieve their development goals efficiently and with high quality. For specific project details and to discuss cooperation, please contact us by phone.